Original ArticleDepression and Anxiety Disorders in Palliative Cancer Care
Key Words
Cited by (0)
The Ottawa Hospital Rehabilitation Center (K.G.W.), Ottawa, Ontario; Clinical Epidemiology Program, (K.G.W., M.G.S., J.J.C.), Ottawa Health Research Institute, Ottawa, Ontario; Department of Psychiatry (H.M.C.), University of Manitoba, Winnipeg, Manitoba; Department of Medicine (P.A.), University of Ottawa, Ottawa, Ontario; Department of Family Medicine (S.C.), University of Saskatchewan, Saskatoon, Saskatchewan; Faculty of Pharmacy (P.G.), Université Laval, Québec, Québec; Tertiary Palliative Care Program (K.M.), Grey Nuns Community Hospital, Edmonton, Alberta; Palliative Care Team (M.D.L.), British Columbia Cancer Agency – Center for the Southern Interior, Kelowna, British Columbia; Dr. H. Bliss Murphy Cancer Center (F.O.), St. John's, Newfoundland; Department of Family and Community Medicine (D.K.), University of British Columbia, Vancouver, British Columbia; and Division of Palliative Care Medicine (R.L.F.), Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
The Canadian National Palliative Care Survey was funded by the Canadian Institutes of Health Research (CIHR). Dr. Chochinov is a Tier 1 Canada Research Chair of the CIHR. Dr. Gagnon is a Research Scientist of the National Cancer Institute of Canada, with funds from the Canadian Cancer Society.